Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration.

Kane, Laura E; Mellotte, Gregory S; Conlon, Kevin C; Ryan, Barbara M; Maher, Stephen G

Kane, Laura E; Mellotte, Gregory S; Conlon, Kevin C; Ryan, Barbara M; Maher, Stephen G.

Afiliação

Kane LE; Department of Surgery, Trinity St. James's Cancer Institute, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin D08 W9RT, Ireland.
Mellotte GS; Department of Gastroenterology, Tallaght University Hospital, Dublin D24 NR0A, Ireland.
Conlon KC; Discipline of Surgery, School of Medicine, Trinity College Dublin, Dublin D02 PN40, Ireland.
Ryan BM; Department of Gastroenterology, Tallaght University Hospital, Dublin D24 NR0A, Ireland.
Maher SG; Department of Surgery, Trinity St. James's Cancer Institute, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin D08 W9RT, Ireland.

Cancers (Basel) ; 13(4)2021 Feb 12.

Article em En | MEDLINE | ID: mdl-33673153

Palavras-chave

biomarker; multi-omics; omics; pancreatic cancer; pancreatic cystic lesion; risk

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2021 Tipo de documento: Article